These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38395159)

  • 1. Co-occurrence, toxicity, and biotransformation pathways of metformin and its intermediate product guanylurea: Current state and future prospects for enhanced biodegradation strategy.
    Dong L; Li S; Huang J; Li WJ; Ali M
    Sci Total Environ; 2024 Apr; 921():171108. PubMed ID: 38395159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filling in the Gaps in Metformin Biodegradation: a New Enzyme and a Metabolic Pathway for Guanylurea.
    Tassoulas LJ; Robinson A; Martinez-Vaz B; Aukema KG; Wackett LP
    Appl Environ Microbiol; 2021 May; 87(11):. PubMed ID: 33741630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea.
    Trautwein C; Kümmerer K
    Chemosphere; 2011 Oct; 85(5):765-73. PubMed ID: 21752423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence, Impact, Analysis and Treatment of Metformin and Guanylurea in Coastal Aquatic Environments of Canada, USA and Europe.
    Tao Y; Chen B; Zhang BH; Zhu ZJ; Cai Q
    Adv Mar Biol; 2018; 81():23-58. PubMed ID: 30471658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerobic Degradation of the Antidiabetic Drug Metformin by
    Li T; Xu ZJ; Zhou NY
    Environ Sci Technol; 2023 Jan; ():. PubMed ID: 36624085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental and Full-Life Cycle Exposures to Guanylurea and Guanylurea-Metformin Mixtures Results in Adverse Effects on Japanese Medaka (Oryzias latipes).
    Ussery E; Bridges KN; Pandelides Z; Kirkwood AE; Guchardi J; Holdway D
    Environ Toxicol Chem; 2019 May; 38(5):1023-1028. PubMed ID: 30835871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of the antidiabetic drug Metformin and its ultimate transformation product Guanylurea in several compartments of the aquatic cycle.
    Trautwein C; Berset JD; Wolschke H; Kümmerer K
    Environ Int; 2014 Sep; 70():203-12. PubMed ID: 24954924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress as a potential mechanism by which guanylurea disrupts the embryogenesis of Danio rerio.
    Elizalde-Velázquez GA; Gómez-Oliván LM; Islas-Flores H; Hernández-Navarro MD; García-Medina S; Galar-Martínez M
    Sci Total Environ; 2021 Dec; 799():149432. PubMed ID: 34365262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Metformin and its Metabolite Guanylurea on Fathead Minnow (Pimephales promelas) Reproduction.
    Blackwell BR; Ankley GT; Biales AD; Cavallin JE; Cole AR; Collette TW; Ekman DR; Hofer RN; Huang W; Jensen KM; Kahl MD; Kittelson AR; Romano SN; See MJ; Teng Q; Tilton CB; Villeneuve DL
    Environ Toxicol Chem; 2022 Nov; 41(11):2708-2720. PubMed ID: 35920346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elevated toxicity of the biodegradation product (guanylurea) from metformin and the antagonistic pattern recognition of combined toxicity: Insight from the pharmaceutical risk assessment and the simulated wastewater treatment.
    Gao F; Wen H; Feng S; Li M; Zhu L; Zhang Y; Xi Y; Xiang X
    Sci Total Environ; 2023 Sep; 892():164747. PubMed ID: 37295518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradation of metformin and its transformation product, guanylurea, by natural and exposed microbial communities.
    Poursat BAJ; van Spanning RJM; Braster M; Helmus R; de Voogt P; Parsons JR
    Ecotoxicol Environ Saf; 2019 Oct; 182():109414. PubMed ID: 31301597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A global perspective on the use, occurrence, fate and effects of anti-diabetic drug metformin in natural and engineered ecosystems.
    Briones RM; Sarmah AK; Padhye LP
    Environ Pollut; 2016 Dec; 219():1007-1020. PubMed ID: 27473659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive study of the antidiabetic drug metformin and its transformation product guanylurea in Greek wastewaters.
    Kosma CI; Lambropoulou DA; Albanis TA
    Water Res; 2015 Mar; 70():436-48. PubMed ID: 25562582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wastewater bacteria remediating the pharmaceutical metformin: Genomes, plasmids and products.
    Martinez-Vaz BM; Dodge AG; Lucero RM; Stockbridge RB; Robinson AA; Tassoulas LJ; Wackett LP
    Front Bioeng Biotechnol; 2022; 10():1086261. PubMed ID: 36588930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed sorption characteristics of the anti-diabetic drug metformin and its transformation product guanylurea in agricultural soils.
    Briones RM; Sarmah AK
    Sci Total Environ; 2018 Jul; 630():1258-1268. PubMed ID: 29554747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental Concentrations of the Type 2 Diabetes Medication Metformin and Its Transformation Product Guanylurea in Surface Water and Sediment in Ontario and Quebec, Canada.
    Littlejohn C; Renaud JB; Sabourin L; Lapen DR; Pappas JJ; Tuteja B; Hughes D; Ussery E; Yeung KK; Sumarah MW
    Environ Toxicol Chem; 2023 Aug; 42(8):1709-1720. PubMed ID: 37283207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment.
    Scheurer M; Michel A; Brauch HJ; Ruck W; Sacher F
    Water Res; 2012 Oct; 46(15):4790-802. PubMed ID: 22770965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Methylotrophic Bacterium Growing with the Antidiabetic Drug Metformin as Its Sole Carbon, Nitrogen and Energy Source.
    Chaignaud P; Gruffaz C; Borreca A; Fouteau S; Kuhn L; Masbou J; Rouy Z; Hammann P; Imfeld G; Roche D; Vuilleumier S
    Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate.
    Straub JO; Caldwell DJ; Davidson T; D'Aco V; Kappler K; Robinson PF; Simon-Hettich B; Tell J
    Chemosphere; 2019 Feb; 216():844-854. PubMed ID: 30449313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental risk assessment of metformin and its transformation product guanylurea: II. Occurrence in surface waters of Europe and the United States and derivation of predicted no-effect concentrations.
    Caldwell DJ; D'Aco V; Davidson T; Kappler K; Murray-Smith RJ; Owen SF; Robinson PF; Simon-Hettich B; Straub JO; Tell J
    Chemosphere; 2019 Feb; 216():855-865. PubMed ID: 30385066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.